Back to Stakeholders
Government, Policy & AdvocacyPolicy Advocacy & ReformDrug Policy Reform Organizations
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchCollaborative Research Consortia
Government, Policy & AdvocacyPolicy Advocacy & Reform
Government, Policy & Advocacy
Research, Drug Development & Manufacturing

National Network of Depression Centers

United States
1 Trial

The National Network of Depression Centers (NNDC) is a US non-profit consortium of academic medical centres united to advance the prevention, diagnosis, and treatment of mood disorders through collaborative research, clinical programmes, and policy advocacy, with member institutions spanning more than 25 major academic health systems. The NNDC supported the BIO-K study, an open-label biomarker development trial investigating intravenous ketamine for non-psychotic unipolar major depression and bipolar I/II depression.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Entity type: Research Consortium / Network

Network Scope

US-centered consortium of academic depression centers with shared programming and research initiatives.

Connected Research Organizations

Emory UniversityJohns Hopkins UniversityDuke UniversityUniversity of MichiganUniversity of California, San FranciscoYale UniversityStanford University

Collaboration Notes

Multi-institution depression and mood-disorders network coordinating collaborative research, clinical innovation, and quality initiatives.

Collaboration Info

Quick Facts

Type
Non-Profit
HQ
United States
Website
Visit

Collaborated Trials

1
CompletedIV

The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.

Start Date
Compounds
Ketamine